MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.
复制标题
DOI:
10.1038/nrd3864
复制
发表时间:
2012-11
期刊:
影响因子:
--
通讯作者:
Olson EN
中科院分区:
文献类型:
--
作者:
van Rooij E;Olson EN
In recent years, prominent roles for microRNAs (miRNAs) have been uncovered in several cardiovascular disorders. The ability to therapeutically manipulate miRNA expression and function through systemic or local delivery of miRNA inhibitors, referred to as antimiRs, has triggered enthusiasm for miRNAs as novel therapeutic targets. Here, we focus on the pharmacokinetic and pharmacodynamic properties of current antimiR designs and their relevance to cardiovascular indications, and evaluate the opportunities and obstacles associated with this new therapeutic modality.
登录
查看更多内容
影响因子:
64.8
作者:
Baek, Daehyun;Villen, Judit;Shin, Chanseok;Camargo, Fernando D.;Gygi, Steven P.;Bartel, David P.
通讯作者:
Bartel, David P.
DOI:
10.1165/rcmb.2010-0323oc
发表时间:
2011-08-01
影响因子:
6.4
作者:
Cushing, Leah;Kuang, Ping Ping;Lue, Jining
通讯作者:
Lue, Jining
影响因子:
20.1
作者:
Corsten, Maarten F.;Papageorgiou, Anna;Heymans, Stephane
通讯作者:
Heymans, Stephane
影响因子:
11.1
作者:
Garchow, Barry G.;Encinas, Oscar Bartulos;Leung, Yiu Tak;Tsao, Patricia Y.;Eisenberg, Robert A.;Caricchio, Roberto;Obad, Susanna;Petri, Andreas;Kauppinen, Sakari;Kiriakidou, Marianthi
通讯作者:
Kiriakidou, Marianthi
影响因子:
20.1
作者:
Caruso, Paola;Dempsie, Yvonne;Baker, Andrew H.
通讯作者:
Baker, Andrew H.